vimarsana.com
Home
Live Updates
Traws Pharma Reports First Quarter 2024 Financial Results and Provides Business Update : comparemela.com
Traws Pharma Reports First Quarter 2024 Financial Results and Provides Business Update
Completed acquisition of Trawsfynydd and concurrent $14 million Capital Raise Excellent pipeline progress, led by candidates for COVID 19, influenza, and oncology programs Poised to initiate Phase 2...
Related Keywords
Australia ,
Traws Pharma ,
Mark Guerin ,
Bruce Mackle ,
Werner Cautreels ,
Torrey Pines ,
Securities Exchange ,
Exchange Commission ,
Lifesci Advisors ,
Traws Pharma Inc ,
Chief Executive Officer ,
Proprietary Portfolio Highlights ,
Orbimed Private Investments ,
Securities Act ,
Securities Exchange Act ,
Private Securities Litigation Reform Act ,
Sci Advisors ,
Consolidated Statements ,
Months Ended March ,
comparemela.com © 2020. All Rights Reserved.